OPEN END TURBO LONG - MERCK & CO. Share Price

Certificat

DE000MD36448

Market Closed - Bid/Ask 07:26:16 21/06/2024 BST Pre-market 07:32:52
3.75 EUR -1.06% Intraday chart for OPEN END TURBO LONG - MERCK & CO. 3.765 +0.40%
Current month+14.16%
1 month-1.81%
Date Price Change
21/06/24 3.75 -1.06%
20/06/24 3.79 +7.37%
19/06/24 3.53 -1.67%
18/06/24 3.59 +0.84%
17/06/24 3.56 -3.52%

Delayed Quote Börse Stuttgart

Last update June 21, 2024 at 07:26 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MD3644
ISINDE000MD36448
Date issued 05/04/2022
Strike 89.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.15
Lowest since issue 0.5
Spread 0.05
Spread %1.32%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.7 USD
Average target price
142.7 USD
Spread / Average Target
+10.03%
Consensus